Having trouble accessing articles? Reset your cache.

Outsourcing from Japan

While a growing number of companies in the West are moving at least some of their R&D activities to Asia, Atlas Venture and a group of Japanese investors are thinking in the reverse direction. Shogoo Pharmaceuticals K.K., which recently raised 1.6 billion ($13.6 million) in a series A round, will be based in Japan but do its R&D in Europe. The idea behind the Japanese home base is to take advantage of a perceived demand

Read the full 756 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers